Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma

Clinical Cancer Research

Volumn 5, Issue 10 SUPPL., 1999, Pages

  Burton, J ^a   Mishina, D ^a   Cardillo, T ^a   Lew, K ^a   Rubin, A ^b   Goldenberg, D M ^a   Gold, D V ^a  

^a GARDEN STATE CANCER CENTER   (United States)

^b ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MA5; MONOCLONAL ANTIBODY MA5 I 125; MONOCLONAL ANTIBODY MA5 I 131; MUCIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION ABSORPTION; RADIOIMMUNOTHERAPY; RADIOISOTOPE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CA-15-3 ANTIGEN; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; MULTIPLE MYELOMA; RADIOIMMUNOTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032696426     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Bataille, R., and Harousseau, J. L. Multiple myeloma. N. Engl. J. Med., 336: 1657-1664, 1997.
2. Greipp, P. R., and Witzig, T. Biology and treatment of myeloma. Curr. Opin. Oncol., 8: 20-27, 1996.
3. King, M. A., and Nelson, D. S. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow. Blood. 73: 1925-1935, 1989.
4. Epstein, J., Xiao, H. Q., and He, X. Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Engl. J. Med., 322: 664-668, 1990.
5. Ruiz-Arguelles, G. J., and San Miguel, J. F. Cell surface markers in multiple myeloma. Mayo Clin. Proc., 69: 684-690, 1994.
6. Bergsagel, P. L., Victor-Kobrin, C., Timblin, C. R., Trepel, J., and Kuehl, W. M. A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J. Immunol., 148: 590-596, 1992.
7. Robillard, N., Jego, G., Pellat-Deceunynck, C., Pineau, D., Puthier, D., Mellerin, MP., Barille, S., Rapp, M. J., Harousseau, J. L., Amiot, M., and Bataille, R. CD28, a marker associated with tumoral expansion in multiple myeloma. Clin. Cancer Res., 4: 1521-1526, 1998.
8. Delsol, G., Gatter, K. C., Stein, H., Erber, W. N., Pilford, K. A. F., Zinne, K., and Meason, D. Y. Human lymphoid cells express epithelial membrane antigen: implications for diagnosis of human neoplasms. Lancet, 2: 1124-1129, 1984.
9. Duperry, C., Klein, B., Durie, G. M., Zhang, X., Jourdan, M., Poncelet, P., Favier, F., Vincent, C., Brochier, J., Lenoir, G., and Bataille, R. Phenotype analysis of human myeloma cell lines. Blood, 73: 566-569, 1989.
10. Takahashi, T., Makiguchi, Y., Hinoda, Y., Kakiuchi, H., Nakagawa, N., Imai, K., and Yachi, A. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J. Immunol., 153: 2102-2109, 1994.
11. Kamoshida, S., and Tsutsumi, Y. Expression of MUC-1 glycoprotein in plasma cells, follicular dendritic cells, myofibroblasts and perineural cells: immunohistochemical analysis using three monoclonal antibodies. Pathol. Int., 48: 776-785, 1998.
12. Hilkens, J., Ligtenberg, M. J. L., Vos, H. L., and Litvinov, S. V. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci., 17: 359-363, 1992.
13. Barlogie, B., Jagannath, S., Tricot, G., Desikan, K. R., Fassas, A., and Siegel, D. Advances in the treatment of multiple myeloma. Adv. Intern. Med., 43: 279-320, 1998.
14. Attal, M., Harousseau, J. L., Stoppa, A. M., Sotto, J. J., Fuzibet, J. G., Rossi, J. F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C., and Bataille, R. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N. Engl. J. Med., 335: 91-97, 1996.
15. Barlogie, B., Jagannath, S., Vesole, D. H., Naucke, S., Cheson, B., Mattox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, J., and Tricot, G. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood. 89: 789-793, 1997.
16. Grogan, T. M., Spier, C. M., Salmon, S. E., Matzner, M., Rybski, J., Weinstein, R. S., Scheper, R. J., and Dalton, W. S. P-Glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood, 81: 490-495, 1993.
17. Mongkonsritragoon, W., Kimlinger, T., Ahmann, G., and Greipp, P. R. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis? Leuk. Lymphoma, 29: 577-584, 1998.
18. Raaijmakers, H. G., Izquierdo, M. A., Lokhorst, H. M., de Leeuw, C., Belien, J. A., Bloem, A. C., Dekker, A. W., Scheper, R. J., and Sonneveld, P. Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma. Blood, 91: 1029-1036, 1998.
19. Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vesciom, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J. C., and Lichtenstein, A. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res., 58: 256-262, 1998.
20. Tu, Y., Xu, F. H., Liu, J., Vescio, R., Berenson, J., Fady, C., and Lichtenstein, A. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. Blood, 88: 1805-1812, 1996.
21. Portier, M., Moles, J. P., Mazars, G. R., Jeanteur, P., Bataille, R., Klein, B., and Theillet, C. p53 and RAS gene mutations in multiple myeloma. Oncogene, 7: 2539-2543, 1992.
22. Neri, A., Baldini, L., Trecca, D., Cro, L., Polli, E., and Maiolo, A. T. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood, 81: 128-135, 1993.
23. Mill, W. B., and Griffith, R. The role of radiation therapy in the management of plasma cell tumors. Cancer (Phila.), 45: 647-652,1980.
24. Dimopoulos, M. A., Goldstein, J., Fuller, L., Delasalle, K., and Alexanian, R. Curability of solitary bone plasmacytoma. J. Clin. Oncol., 10: 587-590, 1992.
25. Liebross, R. H., Ha, C. S., Cox, J. D., Weber, D., Delasalle, K., and Alexanian, R. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 41: 1063-1067, 1998.
26. Ozaki, S., Kosaka, M., Wakatsuki, S., Abe, M., Koishihara, Y., and Matsumoto, T. Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood, 90: 3179-3186, 1997.
27. Ozaki, S., Kosaka, M., Harada, M., Nishitani, H., Odomi, M., and Matsumoto, T. Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24. Cancer (Phila.), 82: 2184-2190, 1998.
28. Bayouth, J. E., Macey, D. J., Kasi, L. P., Garlich, J. R., McMillan, K., Dimopoulos, M. A., and Champlin, R. E. Pharmacokinetics, dosimetry and toxicity of holmium-166-DOMTP for bone marrow ablation in multiple myeloma. J. Nucl. Med., 36: 730-737, 1995.
29. Chomczynski, P., and Mackey, K. Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation. Anal. Biochem., 225: 163-164, 1995.
30. Batra, S. K., Kern, H. F., Worlock, A. J., Metzgar, R. S., and Hollingsworth, M. A. Transfection of human Muc1 mucin gene into a poorly differentiated human pancreatic tumor cell line, PANC1: integration, expression and ultrastructural changes. J. Cell. Science, 100: 841-849, 1991.
31. Dion, A. S., Smorodinsky, N. I., Williams, C. J., Wreschner, D. H., Major, P. P., and Keydar, I. Recognition of peptidyl epitopes by polymorphic epithelial (PEM)-specific monoclonal antibodies. Hybridoma. 10: 595-610, 1991.
32. 111Inlabeled monoclonal antibody (MA5) against a mucin-like antigen. Cancer Res., 50: 927s-931s, 1990.
33. Gold, D. V., Lew, K., Malinak, M., and Cardillo, T. Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. Int. J. Cancer, 57: 204-210, 1994.
34. Chizzonite, R., Truitt, T., Desai, B. B., Nunes, P., Podlaski, F. J., Stern, A. S., and Gately, M. K. IL-12 receptor: I. Characterization of the receptor on PHA-activated human lymphoblasts. J. Immunol., 148: 3117-3124, 1992.
35. Siegel, J. A., and Stabin, M. G. Absorbed fractions for electrons and β particles in spheres of various sizes. J. Nucl. Med., 35: 152-156, 1994.
36. Gendler, S. J., Burchell, J. M., Duhig, T., Lamport, D., White, R., Parker, M., and Taylor-Papadimitriou, J. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc. Natl. Acad. Sci. USA, 84: 6060-6064, 1987.
37. Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., and Kufe, D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA, 85: 2320-2323, 1988.
38. Ligtenberg, M. J. L., Vos, H. L., Gennissen, A. M. C., and Hilkens, J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem., 265: 5573-5578, 1990.
39. Lan, M. S., Hollingsworth, M. A., and Metzgar, R. S. Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. J. Biol. Chem., 262: 12863-12870, 1987.
40. Lan, M. S., Batra, S. K., Qi, W-N., Metzgar, R. S., and Hollingsworth M. A. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J. Biol. Chem., 265: 15294-15299, 1990.
41. Gendler, S. J., Spicer, A. P., Lalani, E. N., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Boshell, M., and Taylor-Papadimitriou, J. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis., 144: S42-S47, 1991.
42. Nishimori, I., Perini, F., Mountjoy, K. P., Sanderson, S. D., Johnson, N., Cerny, R. L., Gross, M. L., Fontenot, J. D., and Hollingsworth, M. A., N-Acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic cell extracts. Cancer Res., 54: 3738-3744, 1994.